Percutaneous Valvuloplasty for Bioprosthetic Tricuspid Valve Stenosis

Rana, Gaurav; Malhotra, Rohit; Sharma, Anjali; Kakouros, Nikolaos

doi:10.14503/thij-15-5408

Cited by 7 publications

(4 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In agreement with the available data. 22 , 23 we established that PTMC produced a noteworthy increase in the Mitral Valve Area with a significant splitting of both mitral commissures. The hemodynamic results of PTMC in our study are comparable to several other studies, in which there was a reduction in the trans-mitral pressure gradient average 18 to 6 mm Hg, and also had an average increase in the mitral valve area, from 1 to 2 cm.…”

Section: Discussionmentioning

confidence: 70%

Echocardiographic assessment before and after Percutaneous Transvenous Mitral Commissurotomy in patients with Rheumatic Mitral Stenosis

Khan¹,

Shafiq²,

Jan

et al. 2020

Pak J Med Sci

View full text Add to dashboard Cite

Objectives: To determine the changes produced in mitral valve morphology after Percutaneous Trans-Venous Mitral Commissurotomy. Methods: Patients with mitral stenosis who underwent PTMC at the cardiology department of Lady Reading Hospital, Peshawar, Pakistan, from 2006-2016 were included in this study. All the data were manually obtained from the electronic medical record (M.F.E.). Wilkin’s echocardiographic scoring system was used to assess the severity of mitral valve thickness, leaflet mobility, valvular calcification, and Subvalvular disease. The student t-test was used for mean comparison. P-value < 0.05 was considered significant. Results: Of the total 229 patients, males were 96(41.9%), and females were 133(58.1%). The mean [SD] age of the patients was 25 ± 11years. The total Wilkin score was 7 ±1.5. 151(65.9%) were in New York Heart Association (NYHA) functional class III, and 78(34.1%) were in NYHA class IV. There was no immediate change after PTMC in systolic myocardial velocities (SV) measured at the lateral tricuspid annulus. The 2D mitral valve area increased from 0.98±0.94 cm2 to 1.78 ± 0.44 cm2 (P=0.001). Left Atrium diameter was 5.16±0.75 mm prior to PTMC, significantly decreased to 4.7± 0.7 mm (p=0.005) after PTMC. Ejection fraction (Left Ventricular Ejection Fraction) changed from 60.45± 8.25 mm Hg to 62.76±10 mm Hg (p=0.001). Mean Right Ventricular Ejection Fraction (RVEF) of patients before PTMC was 48.7 ± 4.7%, did not change significantly immediately after PTMC. Conclusion: PTMC is associated with significant changes in mitral valve morphology in terms of splitting of the fused mitral commissures, increased MVA, improved leaflet excursion, and splitting of the subvalvular structures. doi: https://doi.org/10.12669/pjms.37.1.2446 How to cite this:Khan A, Shafiq I, Jan M, Hassan Z. Echocardiographic assessment before and after Percutaneous Transvenous Mitral Commissurotomy in patients with Rheumatic Mitral Stenosis. Pak J Med Sci. 2021;37(1):104-108. doi: https://doi.org/10.12669/pjms.37.1.2446 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

show abstract

Section: Discussionmentioning

confidence: 70%

Echocardiographic assessment before and after Percutaneous Transvenous Mitral Commissurotomy in patients with Rheumatic Mitral Stenosis

Khan¹,

Shafiq²,

Jan

et al. 2020

Pak J Med Sci

View full text Add to dashboard Cite

show abstract

“…Edwards SAPIEN valve-in-valve implantation has been utilized for degenerative bioprosthetic tricuspid stenosis in patients for whom the original indication for tricuspid valve replacement was rheumatic heart disease, 8 , 9 or infective endocarditis. 10 , 11 Similar to percutaneous balloon valvuloplasty for bioprosthetic tricuspid stenosis, 12 transcatheter valve-in-valve implantation was an inferior therapeutic alternative acceptable only because it avoided the high-surgical risk associated with redo-surgical tricuspid valve replacement.…”

Section: Discussionmentioning

confidence: 99%

Transcatheter tricuspid valve-in-valve implantation for very early bioprosthetic tricuspid stenosis secondary to pacemaker lead entrapment: a case report

Shaukat

Stys

Styś

et al. 2022

European Heart Journal - Case Reports

View full text Add to dashboard Cite

Background Tricuspid stenosis (native and prosthetic) is rare. Redo-sternotomy for isolated tricuspid replacement is associated with higher risk. Efficacy and durability of transcatheter valve implantation for severe tricuspid stenosis is unclear. Case Summary Successful tricuspid valve-in-valve implantation (Edwards 26 mm Ultra) to exteriorize a retained, unextractable pacemaker lead causing very early surgical bioprosthetic valve dysfunction in a 66 -year-old Caucasian woman. The original indication for surgical replacement was pacemaker-lead-related severe tricuspid regurgitation. History of CABG and subsequent surgical replacement rendered risk of a third sternotomy and open-heart surgery prohibitive. Conclusion Successful reduction in severity of bioprosthetic tricuspid stenosis and improvement of right heart failure with transcatheter valve-in-valve implantation. Percutaneous tricuspid valve implantation could be considered an alternative to redo-sternotomy for severe bioprosthetic tricuspid stenosis.

show abstract

“…His hepatic function also was thought to be insufficient for highly-invasive surgery. Therefore, the through 2017 [10]. In their review of 15 articles, 19 cases were identified and in 18 of these 19 cases (95%), the authors reported a successful reduction of the transvalvular pressure gradient.…”

Section: Case Reportmentioning

confidence: 99%

Percutaneous Transcatheter Balloon Valvuloplasty for Bioprosthetic Tricuspid Valve Stenosis in a Patient with Adult Congenital Heart Disease: A Case Report

Manabu¹,

Sugano²,

Matsumoto³

et al. 2018

Int J Clin Cardiol

View full text Add to dashboard Cite

A 38-year-old male with previous surgeries for an incomplete atrioventricular septal defect successfully underwent percutaneous transcatheter tricuspid balloon valvuloplasty for a deteriorated bioprosthetic valve. Our case highlights the imperative of considering catheter-based minimally invasive therapy for the increasing number of adults with congenital heart disease who may present multiple risks factors for surgery.

show abstract

Percutaneous Valvuloplasty for Bioprosthetic Tricuspid Valve Stenosis

Cited by 7 publications

References 20 publications

Echocardiographic assessment before and after Percutaneous Transvenous Mitral Commissurotomy in patients with Rheumatic Mitral Stenosis

Echocardiographic assessment before and after Percutaneous Transvenous Mitral Commissurotomy in patients with Rheumatic Mitral Stenosis

Transcatheter tricuspid valve-in-valve implantation for very early bioprosthetic tricuspid stenosis secondary to pacemaker lead entrapment: a case report

Percutaneous Transcatheter Balloon Valvuloplasty for Bioprosthetic Tricuspid Valve Stenosis in a Patient with Adult Congenital Heart Disease: A Case Report

Contact Info

Product

Resources

About